(Credit-Canva)
Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!
The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.
"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.
The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.
While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.
And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.
Credit: Canva
Rising global temperatures are driving heatwave conditions in India, said the Indian government, while releasing an advisory to warn people about the increased health risks.
Taking to the social media platform X, the Ministry of Health and Family Welfare urged the public to take precautions during extreme heat.
"Heat waves are increasing due to rising global temperatures," said the Ministry in the advisory.
It shared safety measures and an informative poster explaining the impact of rising temperatures and steps to manage heat stroke.
The poster highlighted that a rise of 1 degree Celsius in global temperatures can lead to longer durations of heatwaves.
Further, it stated that insufficient hydration during heatwaves reduces the body's natural ability to cool itself, which can result in heat stroke.
The poster also detailed preventive measures to avoid heat stroke. It also advised people to avoid heavy work during mid-noon hours, drink plenty of water, avoid consuming heavily caffeinated or sugary drinks as they may cause dehydration, wear light-colored clothes, and take frequent breaks while working outdoors.
The India Meteorological Department (IMD) has warned of heatwave conditions in several parts of the country.
Regions likely to face extreme heatwave conditions until April 20 include Telangana and Rayalaseema, Madhya Maharashtra and Marathwada, North Interior Karnataka, Madhya Pradesh, Chhattisgarh, Vidarbha, Odisha, Jharkhand, and West Rajasthan.
In addition, hot and humid weather conditions are expected in coastal regions such as Kerala, Tamil Nadu, Gujarat, and Coastal Andhra Pradesh.
Meanwhile, the national capital saw its hottest day of the year on Wednesday, as temperatures climbed sharply, signaling the onset of harsher summer conditions. According to IMD, the maximum temperature at Safdarjung, the city’s base station, touched 39.2 degrees Celsius, about 3 degrees above normal. This surpassed Tuesday’s 38.2 degrees Celsius, marking a noticeable upward trend.
While the mercury is expected to inch closer to 42 degrees Celsius by Friday, the weather office has ruled out heatwave conditions for at least the next week.
“A gradual rise is expected in maximum temperatures by 2-3 degrees during the next three days and fall by 1-2 degrees thereafter. The maximum temperatures are likely to be above normal to appreciably above normal during the next seven days," Times Of India quoted a Met official as saying.
As per the weather department, despite a slight chance of light rain in parts of Haryana and NCR on April 17 and 18, there is no relief expected for Delhi.
Forecasts suggest daytime temperatures will hover between 39 degrees Celsius and 41 degrees Celsius on Thursday, rising further to 40-42 degrees Celsius from Friday through Sunday.
The IMD has cautioned that such above-normal temperatures could pose moderate health risks, especially for infants, elderly individuals, and those with chronic illnesses.
Dr. Anil Gomber, Director and Senior Consultant – Internal Medicine & Diabetologist, Yatharth Hospital, told HealthandMe: “It is crucial to take preventive measures to avoid heat-related illnesses".
Prolonged exposure to high temperatures can lead to dehydration, heat exhaustion, and heatstroke, which can be fatal if untreated.
Heat also places extra strain on the heart and lungs, increasing the risk of heart attacks and respiratory distress.
Heatwaves can increase the risk of deaths among the elderly and those with underlying medical conditions. It can also affect healthy and young people. Exposure to intense heat can cause headaches, dizziness, cramps, and fainting, particularly for those working outdoors or engaging in strenuous activity.
"Elderly people, kids, and those with chronic conditions like heart disease or diabetes face higher risks, so check on neighbors and family daily," Dr. Meenakshi Jain Principal Director & HOD Internal Medicine, Max Super Speciality Hospital, told HealthandMe.
She urged people to "watch for warning signs like dizziness, rapid heartbeat, nausea, or confusion, and move to a cool area immediately if they appear—seek medical help for severe symptoms. Keep homes cooler by closing curtains during the day and opening windows at night".
Credit: Canva
More than 3 million eye drops have been recalled by the US Food and Drug Administration (FDA) over sterility concerns.
The FDA, in its Enforcement Reports, stated that the products recalled “lack assurance of sterility.”
While so far, there are no reports of injuries associated with the eye drops, the FDA notice classified the action as a “Class II recall.”
Class II recalls apply to products that can cause “temporary or medically reversible” health problems.
The 3,111,072 products were manufactured by California-based K C Pharmaceuticals and were sold under names such as “Dry Eye Relief Eye Drops,” “Sterile Eye Drops,” and “Artificial Tears Sterile Lubricant Eye Drops,” according to the FDA notice.
California-based K C Pharmaceuticals made the voluntary recall of the eye drops in early March.
The eight types of eye drop products were sold at major retailers, including CVS, Walgreens, and Rite Aid. They have expiration dates ranging from April to October.
“The recall is very large, potentially affecting over a million people,” said C. Michael White, clinical pharmacologist and pharmacist at the University of Connecticut, in a Commentary published in The Conversation.
He added that “using nonsterile eye drops that harbor bacteria and fungus can cause eye infections, which can become severe because the immune system has a hard time accessing the eyeball and fighting the microbes”.
However, other experts stated that infections from eye drops are rare. Notably, the current voluntary recall has not reported any infections to date.
According to Jeffrey H. Ma, an ophthalmologist at the University of California-Davis Health, people with dry eyes must use preservative-free drops that come in disposable single-use vials. He advised people to dispose of any eye drops included in the recall.
“Drops that are not on the recall list should be safe to use,” said Ma. “If you have any of the drops on the list, you should immediately throw them away.”
Beyond contaminated eye drops, several common eye infections can be triggered by environmental factors such as sun exposure, dust, and dirt—especially among people who work outdoors or spend long hours in front of screens.
“Conjunctivitis, known as pink eye, is the most common type of eye infection,” Ma said. Pink eye is estimated to affect about six million people every year.
“It is usually viral or bacterial, and is transmitted through direct contact, such as touching or rubbing your eyes after touching a contaminated item,” Ma added.
Contact lens wearers also have a higher risk of eye infections, particularly if they sleep in their lenses.
Symptoms of an eye infection include:
Experts urged investing in good sunglasses with ultraviolet protection and maintaining proper hygiene, such as washing hands before touching the lenses.
"For those who are using computers a lot, you need to blink your eyes constantly, take breaks in between, and drink a lot of water. Dehydration is also a contributing factor to dry eye," Dr Anita Sethi, who is Principal Director and HOD Ophthalmology, Max Multi Specialty Centre at Panchsheel Park.
She also recommends using zero-number protective glasses and computer glasses that can decrease strain and dry eye.
While advising people to stay away from natural remedies like turmeric or ginger put inside the eye, Dr Sethi urged people to consume more “foods rich in vitamin E, antioxidants” to maintain eye health.
Credit: iStock
India needs clearer guidelines on reproductive rights, consent, and medical ethics, said doctors after the Delhi High Court, in a highly complex and sensitive case, granted permission for the extraction and cryopreservation of sperm of an Indian Army soldier in a persistent vegetative state.
As per the guidelines laid under the Assisted Reproductive Technology (ART) (Regulation) Act, 2021, it is important to have the written consent of both partners.
However, calling it “the right to reproductive autonomy,” Justice Purushaindra Kumar Kaurav allowed for sperm retrieval. The Court also cited the soldier's prior consent to undergo IVF treatment with his wife. "It constituted valid consent under the ART Act," LiveLaw reported.
The wife of an Indian Army soldier had approached the Court seeking directions to allow the retrieval and preservation of her husband's genetic material to enable her to undergo IVF.
Her husband, an Indian Army soldier, suffered a severe traumatic brain injury during deployment in Jammu and Kashmir in July last year and has since remained in a persistent vegetative state.
Before the incident, the couple had already opted for IVF and initiated procedures. However, the process was halted due to the husband's inability to provide fresh written consent as required under Section 22 of the ART Act, Live Law reported.
“While ...as on date there is no express indication of consent from the petitioner's husband, however, under the facts and circumstances of the present case, it is found to be fair, reasonable, and just for the respondents to undertake the necessary procedure/steps which are required to take the IVF treatment to its logical conclusion. But for this, the original consent given by the petitioner's husband shall stand vitiated, and the very purpose for acceding to the IVF treatment shall be rendered otiose,” said Justice Kaurav, in the Court's ruling.
“It is further directed that the petitioner's consent be considered as valid consent for her husband for the purposes of IVF procedure, if the same is required for any other step/procedure. The respondents shall not disentitle the petitioner on the sole ground that the petitioner's husband's written consent is absent,” the Court said.
HealthandMe spoke to IVF specialists to understand the procedure and implications around reproductive rights, consent, and medical ethics.
Dr Rachita Munjal, Director and Senior Consultant - Department of Fertility at Cloudnine Group of Hospitals, Gurugram, said that sperm retrieval and cryopreservation are possible in coma/vegetative patients, but success depends on timing and medical condition.
Also read: Explained: What Is Posthumous Reproduction?
In such conditions, sperm quality may be compromised, but assisted reproductive techniques can still make conception possible.
"Cryopreservation of sperm in men who are in a vegetative state or coma is medically complex but technically feasible in many cases, depending on the underlying condition and timing," the doctor told HealthandMe.
Since the person cannot ejaculate voluntarily, doctors use assisted techniques, such as
These are typically performed by urologists or fertility specialists with consent from legal guardians or prior consent of the patient. Once sperm is obtained:
There are many ethical considerations in such cases, said Dr Munjal, noting that this requires explicit prior consent or legal authorization.
“Ethical concerns include reproductive rights and future child welfare,” she added.
Dr. Sabine Kapasi, IVF Specialist & Public Health Strategist, called it “an emotionally sensitive case where law, ethics, and reproductive rights intersect”.
“While prior IVF consent may indicate shared intent to build a family, it does not always automatically equal consent for gamete retrieval during permanent incapacity. Such decisions should ideally involve explicit consent, ethics review, and psychological counseling for the family,” the expert said.
This is not the first time that sperm have been retrieved from a comatose patient.
In 2024, a Kerala High Court permitted the extraction of the sperm of a childless couple where the husband was in a brain-dead condition and kept alive with ventilator support. The Court allowed the extraction and cryopreservation of the gametes, without the written consent of the husband.
"India now needs clearer ART guidelines for coma, posthumous, and incapacity-related reproduction to avoid future disputes. Compassion is important, but medical ethics and long-term child welfare must remain central,” Dr Kapasi noted.
© 2024 Bennett, Coleman & Company Limited